These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26978505)

  • 1. [Functional properties of dopaminergic neurons obtained from fibroblasts of a patient with PARK2 form of Parkinson's disease].
    Konovalova ЕV; Ivashkin ЕG; Lopachev АV; Lopacheva ОМ; Komissarov АА; Grivennikov IА; Novosadova ЕV; Dashynimaev EB; Fedotova ЕY; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):123-127. PubMed ID: 26978505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.
    Kuzumaki N; Suda Y; Iwasawa C; Narita M; Sone T; Watanabe M; Maekawa A; Matsumoto T; Akamatsu W; Igarashi K; Tamura H; Takeshima H; Tawfik VL; Ushijima T; Hattori N; Okano H; Narita M
    Brain; 2019 Jun; 142(6):1675-1689. PubMed ID: 31135049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
    Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
    Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
    Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
    Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2).
    Antonini A; Moresco RM; Gobbo C; De Notaris R; Panzacchi A; Barone P; Bonifati V; Pezzoli G; Fazio F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S51-2. PubMed ID: 12548339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake.
    Luk B; Mohammed M; Liu F; Lee FJ
    PLoS One; 2015; 10(8):e0136641. PubMed ID: 26305376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
    Okarmus J; Bogetofte H; Schmidt SI; Ryding M; García-López S; Ryan BJ; Martínez-Serrano A; Hyttel P; Meyer M
    Sci Rep; 2020 Jun; 10(1):10278. PubMed ID: 32581291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease.
    Herborg F; Jensen KL; Tolstoy S; Arends NV; Posselt LP; Shekar A; Aguilar JI; Lund VK; Erreger K; Rickhag M; Lycas MD; Lonsdale MN; Rahbek-Clemmensen T; Sørensen AT; Newman AH; Løkkegaard A; Kjærulff O; Werge T; ; Møller LB; Matthies HJ; Galli A; Hjermind LE; Gether U
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Phenylethylamine requires the dopamine transporter to increase extracellular dopamine in Caenorhabditis elegans dopaminergic neurons.
    Hossain M; Wickramasekara RN; Carvelli L
    Neurochem Int; 2014 Jul; 73():27-31. PubMed ID: 24161617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile parkinsonism-dystonia: a dopamine "transportopathy".
    Blackstone C
    J Clin Invest; 2009 Jun; 119(6):1455-8. PubMed ID: 19504720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Parkinsonian toxin MPP+ on electrophysiological properties of nigral dopaminergic neurons.
    Yee AG; Lee SM; Hunter MR; Glass M; Freestone PS; Lipski J
    Neurotoxicology; 2014 Dec; 45():1-11. PubMed ID: 25193392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
    J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
    Masoud ST; Vecchio LM; Bergeron Y; Hossain MM; Nguyen LT; Bermejo MK; Kile B; Sotnikova TD; Siesser WB; Gainetdinov RR; Wightman RM; Caron MG; Richardson JR; Miller GW; Ramsey AJ; Cyr M; Salahpour A
    Neurobiol Dis; 2015 Feb; 74():66-75. PubMed ID: 25447236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.
    Konovalova EV; Novosadova EV; Grivennikov IA; Illarioshkin SN
    Bull Exp Biol Med; 2015 Oct; 159(6):772-5. PubMed ID: 26519280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines.
    Shaltouki A; Sivapatham R; Pei Y; Gerencser AA; Momčilović O; Rao MS; Zeng X
    Stem Cell Reports; 2015 May; 4(5):847-59. PubMed ID: 25843045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic Neuronal Differentiation from the Forebrain-Derived Human Neural Stem Cells Induced in Cultures by Using a Combination of BMP-7 and Pramipexole with Growth Factors.
    Yang H; Wang J; Wang F; Liu X; Chen H; Duan W; Qu T
    Front Neural Circuits; 2016; 10():29. PubMed ID: 27147976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.